Patients suspecting they have multiple sclerosis (MS) are encountering significant delays in accessing specialist care, with ...

Patients suspecting they have multiple sclerosis (MS) are encountering significant delays in accessing specialist care, with ...

People with MS are more than twice as likely to experience headaches, including migraines, than their healthy counterparts, ...

Multiple sclerosis, which affects around one in 500 people in Switzerland, is an autoimmune disease in which immune cells ...

Sleep disorders are highly prevalent among individuals with multiple sclerosis (MS), affecting nearly half of the patient population, according to study results presented at the European Committee for ...

Andrew Wolf, MD, discusses the growing costs, treatment advances, and geographic disparities in multiple sclerosis care.

Once-yearly infusions of rituximab are as effective as twice-yearly dosing for sustained control of MS in a new phase 3 trial ...

Most people with relapsing MS who were treated with Briumvi for six years did not have confirmed disability progression, a ...

Disconnectome mapping provides a comprehensive understanding of how structural damage translates to cognitive dysfunction. Lesion-based disconnectome mapping suggests that the pattern, not the ...

The ALS and MS Walk for Living took place today in Chelsea, drawing around 600 participants to support the Leonard Florence ...

Patients with MS receiving ocrelizumab are at higher risk for serious infection compared with those treated with platform injectable therapies.

In this interview, Steven Buslovich, M.D., CMD, MS, chief medical officer of senior care at PointClickCare, explains the ...